Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma
about
Exploring targeted therapy of osteosarcoma using proteomics dataClinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma.Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications.Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms.Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors.
P2860
Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@ast
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@en
type
label
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@ast
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@en
prefLabel
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@ast
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@en
P2093
P2860
P356
P1433
P1476
Identification of Synergistic, ...... ion Therapies for Osteosarcoma
@en
P2093
Christopher L Cubitt
Conor C Lynch
Daniel M Sullivan
Elliot Kahen
Jenny Kreahling
Jeremy McGuire
Soner Altiok
P2860
P2888
P356
10.1038/SREP16991
P407
P577
2015-11-25T00:00:00Z